Abstract
THE main receptor for the human immunodeficiency viruses type 1 and 2 (HIV-1 and HIV-2) on T and B lymphocytes, monocytes and macrophages is the CD4 antigen1–3. Infection of these cells is blocked by monoclonal antibodies to CD41,2 and by recombinant soluble CD44–9. Expression of transfected CD4 on the surface of HeLa and other human cells renders them susceptible to HIV infection10. HIV-antibody complexes can also infect monocytes and macrophages by means of receptors for the Fc portion of immunoglobulins (FcR)11–13), or complement receptors14,15. The expression of IgG FcRs can be induced in cells infected with human herpes viruses such as herpes simplex virus type 1 (HSV-1)16,17 and human cytomegalovirus (CMV)18–21. Here we demonstrate that FcRs induced by CMV allow immune complexes of HIV to infect fibroblasts otherwise not permissive to HIV infection. Infection was inhibited by prior incubation with human IgG, but not by anti-CD4 antibody or by recombinant soluble CD4. Once HIV had entered CMV-infected cells by means of the FcR, its replication could be enhanced by CMV transactivating factors. Synergism between HIV and herpes viruses could also operate in vivo, enhancing immunosuppression and permitting the spread of HIV to cells not expressing CD4.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Dalgleish, A. G. et al. Nature 312, 763–767 (1984).
Klatzmann, D. et al. Nature 312, 767–768 (1984).
Sattentau, Q. J. & Weiss, R. A. Cell 52, 631–633 (1988).
Smith, D. H. et al. Science 238, 1704–1707 (1987).
Fisher, R. A. et al. Nature 331, 76–78 (1988).
Hussey, R. E. et al. Nature 331, 78–81 (1988).
Deen, K. C. et al. Nature 331, 82–84 (1988).
Traunecker, A., Luke, W. & Karjalainen, K. Nature 331, 84–86 (1988).
Clapham, P. R. et al. Nature 337, 368–370 (1989).
Maddon, P. A. et al. Cell 47, 333–348 (1986).
Takeda, A., Tuazon, C. U. & Ennis, F. A. Science 242, 580–583 (1988).
Homsy, J., Tateno, M. & Levy, J. A. Lancet i, 1285–1286 (1988).
Homsy, J., Meyer, M., Tateno, M., Clarkson, S. & Levy, J. A. Science 244, 1357–1360 (1989).
Robinson, W. E., Montefiori, D. C. & Mitchell, W. M. Lancet i, 790–794 (1988).
Robinson, W. E., Montefiori, D. C., Gillespie, D. H. & Mitchell, W. M. J. AIDS 2, 33–42 (1989).
Watkins, J. F. Nature 202, 1364–1365 (1964).
Westmoreland, D. & Watkins, J. F. J. gen. Virol. 24, 167–178 (1974).
Furukawa, T., Hornberger, E., Sakuma, S. & Plotkin, S. A. J. clin. Microbiol. 2, 332–336 (1975).
Keller, R., Peitchel, R., Goldman, J. N. & Goldman, M. J. Immun. 116, 772–777 (1976).
Westmoreland, D., St. Jeor, S. & Rapp, F. J. Immun. 116, 1566–1570 (1976).
Frey, J. & Einsfelder, B. Eur. J. Biochem. 138, 213–216 (1984).
Moore, J. & Jarrett, R. AIDS 4, 369–379 (1988).
Clapham, P. R. et al. Virology 158, 44–51 (1987).
Saiki, R. K., Bugawan, T. L., Horn, G. T., Mullis, K. B. & Erlich, H. A. Nature 324, 163–166 (1986).
Berry, N. J., Grundy, J. E. & Griffiths, P. D. J. virol. Meth. 13, 343–350 (1986).
Kinney-Thomas, E. et al. AIDS 2, 25–29 (1988).
Tateno, M., Gonazles-Scarano, F. & Levy, J. A. Proc. natn. Acad. Sci. U.S.A. 86, 4287–4290 (1989).
Unkeless, J. C., Scigliano, E. & Freedman, V. H. A. Rev. Immun. 6, 251–281 (1988).
Murayama, T., Natsuume-Sakai, S., Shimokowa, K. & Furukawa, T. J. gen. Virol. 67, 1475–1478 (1986).
Mintz, L., Drew, W. L., Miner, R. C. & Braff, E. H. Ann. intern. Med. 99, 326–329 (1983).
Reichert, C. M., O'Leary, T. J., Levens, D. L., Simrell, C. R. & Macher, A. M. Am. J. Path. 112, 357–382 (1983).
Drew, W. L., Sweet, E. S., Miner, R. C. & Mocarski, E. S. J. infect. Dis. 150, 952–953 (1984).
Spector, S. A., Hirata, K. K. & Neuman, T. R. J. infect. Dis. 150, 953–956 (1984).
Davis, M. G., Kenney, S. C., Kamaine, J., Pagano, J. S. & Huang, E.-S. Proc. natn. Acad. Sci. U.S.A. 84, 8642–8646 (1987).
Skolnik, P. R., Kosloff, B. R. & Hirsch, M. S. J. infect. Dis. 157, 508–514 (1988).
Webster, A. et al. Lancet ii, 63–65 (1989).
Fiala, M., Cone, L. A., Chang, C.-M. & Mocarski, E. S. AIDS Res. 2, 175–181 (1986).
Gonczol, E. & Schnitzer, T. J. J. gen. Virol. 43, 691–695 (1979).
Cecilia, D., Gadkari, D. A., Kedarnath, N. & Gnosh, S. N. J. gen. Virol. 69, 2741–2747 (1988).
Halstead, S. B. Science 239, 476–481 (1988).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
McKeating, J., Griffiths, P. & Weiss, R. HIV susceptibility conferred to human fibroblasts by cytomegalovirus-induced Fc receptor. Nature 343, 659–661 (1990). https://doi.org/10.1038/343659a0
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/343659a0
This article is cited by
-
HIV-1 DNA in fibroblast cultures infected with urine from HIV-seropositive cytomegalovirus (CMV) excretors
Archives of Virology (1995)
-
Mutual interactions between HIV-1 and cytokines in adherent cells during acute infection
Archives of Virology (1994)
-
Cytomegalovirus as a co-factor of disease progression in human immunodeficiency virus type 1 infection
International Journal of Clinical & Laboratory Research (1994)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.